CPT Group, Inc.

Revance Therapeutics, Inc. is a Nashville-based company that is revolutionizing healthcare through the development, acquisition, and commercialization of innovative aesthetic and therapeutic offerings. With a focus on elevating patient and physician experiences, Revance is setting a new standard in the industry. Their diverse portfolio includes products such as the long-lasting, peptide-powered frown line treatment, DaxibotulinumtoxinA for Injection, which is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines. Backed by 20 years of investment in research and development, Revance is committed to growth and is always seeking talented individuals to join their team. Driven by a mission to provide cutting-edge solutions, Revance is dedicated to improving the lives of patients. Their pipeline includes the development of hyaluronic acid fillers and long-acting neuromodulators, offering a comprehensive range of aesthetic and therapeutic options. With a focus on safety and efficacy, Revance ensures that their products meet the highest standards. As a leader in the industry, Revance is shaping the future of healthcare and offering exciting career opportunities for those looking to make a difference in the field.Generated from the website